BeOne Medicines ONC Earnings Call Transcripts

NASDAQ ONC
$387.14 +9.36 (+2.48%)
As of: Nov 5, 2026 · 3:59 PM EST
1 earnings call on file for BeOne Medicines, Q2 2026. Each transcript opens in a new tab.
Latest earnings call

BeOne Medicines Q2 2026 Earnings Call

Aug 5, 2026 8,064 words · 35 min read
  • Daniel MallerHead of Investor Relations
  • John OylerCo-Founder, Chairman and Chief Executive Officer
  • Aaron RosenbergChief Financial Officer
  • Lai WangPresident and Global Head of R&D
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

BeOne Medicines Earnings Call Transcripts

Calls1
LatestAug 5, 2026
SinceQ2 2026

Fiscal 2026

All 1 BeOne Medicines transcript Register to get access to BeOne Medicines’s earnings call transcripts.